Association Between Bottle Size and Formula Intake in 2-Month-Old Infants

Charles T Wood1, Asheley C Skinner1, H Shonna Yin2

  • 1Division of General Pediatrics and Adolescent Medicine, Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.

Academic Pediatrics
|November 4, 2015
PubMed

Insights

Using larger bottles for infant formula is linked to higher daily intake. This may increase the risk of overfeeding and childhood obesity in formula-fed infants.

Area of Science:

  • Pediatrics
  • Nutrition Science
  • Public Health

Background:

  • Infant feeding practices significantly influence growth and long-term health outcomes.
  • Understanding factors associated with infant formula consumption is crucial for preventing obesity.
  • Bottle size is a potential, modifiable factor in infant feeding volume.

Purpose of the Study:

  • To determine the range of infant bottle sizes utilized.
  • To investigate the association between infant bottle size and total daily infant formula consumption.

Main Methods:

  • Cross-sectional analysis of baseline data from the Greenlight cluster randomized trial.
  • Included healthy, term infants exclusively formula-fed at 2 months.
  • Parents reported volume per feed, feeds per day, and bottle size (dichotomized as <6 oz or ≥6 oz).
  • Statistical analysis adjusted for infant age, sex, weight, race/ethnicity, and WIC enrollment.

Main Results:

  • 44% of 865 infants were exclusively formula-fed at 2 months.
  • 46% of infants were fed with larger bottles (≥6 oz).
  • Parents using larger bottles reported feeding an average of 4 oz more formula daily (34.2 oz vs. 29.7 oz).

Conclusions:

  • Larger bottle size is associated with increased reported formula intake in exclusively formula-fed infants.
  • This association suggests a potential risk of overfeeding when using larger bottles.
  • Overfeeding may contribute to increased risk of obesity in infants.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
751
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
712
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
462
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
34
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
517